Prof. Mojisola Adeyeye, director general of the National Agency for Food and Drug Administration and Control (NAFDAC), has affirmed that Nigerian herbal medicines have the potential to meet global standards if subjected to rigorous scientific testing.
Speaking on the agency’s collaboration with the Nigeria Natural Medicine Development Agency (NNMDA), Adeyeye emphasized the critical role of clinical trials in validating the safety and efficacy of indigenous herbal remedies.
The DG explained that NAFDAC employs two approval types for herbal medicines: a two-year listing approval, granted after satisfactory toxicology safety tests, and a five-year full approval, which requires clinical trials to confirm efficacy.